reported that LEX did not exert the expected effect when binding to CD4+T cells due to insufficient costimulatory ability, CD4+T-LEX-CD8086 was constructed, which could stimulate antigen-specific CD8+ cytotoxic T cell responses to leukemia cells. This evidence concerns the gene CD4 and leukemia.